Table 5.

Literature review of tantalum rod

	Hips	Design	Patient selection (hips)	Follow-up (Mons)	Survivorship	End point
Tsao et al. (2005) [24]	94	Prospective	Steinberg I (1) II(93)	48	72.5% at 48mons	THA
Veilette et al. (2006) [23]	58	Retropective	Steinberg I (1) II(49) III (8) (1)II(93)StageI(1)II(49)l(8)	24	68.1% at 48mons	THA
Nadeau et al. (2007) [13]	18	Prospective	Steinberg III (3) IV(15)	23.2	42.5% at 48mons	THA
Varitimidis et al. (2009) [16]	26	Prospective	Steinberg I (9) II(7) III (10)	38	70% at 6 years	THA
Liu et al. (2010) [25]	49	Prospective	Steinberg I (21) II (26) IIIA(2)	15.2	83.7%	THA
Floerkemeier et al. (2011) [22]	23	Retropective	ARCO I II	529(days)	44%	THA
Liu et a al. (2013) [26]	94	Prospective	Steinberg I (27) II (49) III(18)	37.3	I 88.9% II 79.6% III 55.6%	THA
Ma et al. (2016) [27]	104	Retrospective	ARCO II(42) III(62)	42	52.9%	THA
Hu et al. (2018) [28]	29	Prospective	ARCO I (5) II(24)	5.4 (year)	93.1%	THA